Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cereno Scientific announces initiation of Multiple Ascending Dose (MAD) part of Phase I trial of the novel HDAC inhibitor CS014

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for diseases with high unmet medical needs, today announced that the Company has initiated the Multiple Ascending Dose (MAD) part of the first-in-man Phase I trial of novel HDACi CS014, after the Safety Monitoring Committee ensuring that the safety profile in the Single Ascending Dose (SAD) part is within acceptable limits. The CS014 development program is targeting rare disease Idiopathic Pulmonary Fibrosis (IPF).The MAD part (Part II) of the Phase I trial will explore safety, tolerability,

Insider information: Alisa Bank Plc appoints Sampsa Laine as CEO and chair of the management team

ALISA BANK PLC STOCK EXCHANGE RELEASE, INSIDE INFORMATION, 14.11.2024 AT 9.00 EETThe Board of Directors of Alisa Bank Plc has appointed Sampsa Laine (Master of Science (Econ.) as CEO and chair of the management team. Laine will start in his position on 1 December 2024. Laine´s membership in Alisa Bank´s Board of Directors will end at the same time. Sampsa Laine has strong expertise in banking and banking related risks. He started his career as an expert and later on as a manager in capital market area in various Northern European banks.  Since 2013 he held leading positions within retail

Q3 EBITDA increased by 34 percent

July – September 2024• Revenue increased by 13 % to 21.7 MSEK (19.2 MSEK)• Revenue from continuing operations increased by 14 % *• EBITDA increased by 34 % to 15.2 MSEK (11.4 MSEK)• The EBITDA margin amounted to 70 % (59 %)• Operating profit (EBIT) amounted to 14.1 MSEK (10.2 MSEK)• Profit after tax amounted to 12.0 MSEK (6.7 MSEK)• Basic and diluted earnings per share: 0.35 SEK (0.20 SEK) January – September 2024• Revenue increased by 14 % to 71.5 MSEK (62.9 MSEK)• Revenue from continuing operations increased by 19 % *• EBITDA increased by 44 % to 51.0 MSEK (35.4 MSEK)

Interim report Q3: Continued growth and record strong quarter for the Consumer division

July - September 2024 · Net sales amounted to SEK 222 million (199). In organic terms net sales increased by 15%. · The gross margin increased to 56.4% (51.6). · Adjusted EBITA increased to SEK 30 million (18), a margin of 13.6% (9.1). · Cash flow from operating activities amounted to SEK -3 million (-14). · The EVSE share of net sales decreased to 15% (18) amounting to SEK 34 million (35). "The third quarter of the year saw continued good growth and improved margins. A strong contributor to this was the Consumer division, which delivered its best third quarter

Bioretec Ltd’s business review January–September 2024: Launch of the RemeOs™ Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage

Bioretec Ltd  Company announcement 14 November 2024 at 8:45 a.m.This announcement summarizes Bioretec Ltd’s business review for January–September 2024. The complete business review is attached to this release as a PDF file and available on the company’s website at https://bioretec.com/investors/investors-in-english/releases.   July – September 2024 in brief · Net sales amounted to EUR 685 thousand (7–9/2023: EUR 483 thousand). · The sales margin (excl. other income) was EUR 499 (397) thousand, or 72.9% (82.2%). The main reasons for the lower sales margin percentage were

Breaking every hour of sedentary time with 10 mins of light exercise significantly reduced blood pressure

Time spent sedentary beyond six hours per day during growth from childhood through young adulthood may cause an excess increase of 4 mmHg in systolic blood pressure, a new study shows. Continuously engaging in light physical activity (LPA) significantly mitigated the rise in blood pressure. The study was conducted in collaboration between the Universities of Bristol and Exeter in the UK, and the University of Eastern Finland, and the results were published in the prestigious Journal of Cachexia, Sarcopenia and Muscle.In the present study, 2,513 children drawn from the University of Bristol’

Gympak expands to Spain with new sales partnership

Gympak, a Swedish leader in wellness solutions known for its innovative fitness apparel, gear, and app-based wellness programs, is pleased to announce its entry into the Spanish market through a new strategic partnership. Michael Scholz and his company has been appointed as the exclusive Business Development Consultant for Gympak in Spain, where he will lead efforts to bring Gympak’s cutting-edge wellness products to the country’s extensive hospitality industry.With this expansion, Gympak aims to tap into Spain’s thriving hotel sector, which includes over 20,000 hotels and resorts. By

Invitation to Scandic Hotels Group’s Capital Markets Day 2025 in Stockholm

Scandic Hotels Group is pleased to invite investors, analysts and media to its Capital Markets Day on February 19, 2025, at Scandic Continental in Stockholm.The purpose of the Capital Markets Day is to present an update on the business plan which forms the basis of the mid-term targets as well as the Group’s strategy and vision for 2030. The day will be led by CEO Jens Mathiesen and CFO Pär Christiansen together with other executives from the company. The event will be held at Scandic Continental at Vasagatan 22, in Stockholm and will be livestreamed for those who aren’t able to attend

Interim report 1 January – 30 September 2024

Q3 2024:  Strong performance in the USTHIRD QUARTER 2024 · Revenue increased by 77% to SEK 1,141m (643) · Operating profit increased to SEK 2m (-10) · Operating margin increased to 0.1% (-4.4) · The result for the period decreased by -1% to SEK -88m (-89) · Basic earnings per share[1] amounted to SEK -6,07 (-6,16) · Cash flows from operating activities amounted to SEK 427m (-88) JANUARY - SEPTEMBER 2024 · Revenue increased by 75% to SEK 3,408m (1,948) · Operating profit increased by 135% to SEK 19m (-53) · Operating margin increased to 0.5% (-2.7) · The

A significant step forward for the quantum secure network in Finland: novel encryption technology tested in a commercial operator’s network

Press release, 14 November 2024 This week Telia successfully tested the ultra-secure quantum encryption technology in its network in Helsinki as the first commercial operator in Finland. The demo is a significant step in a national project which aims to build a quantum secure network for Finland.Quantum key distribution, or QKD, is a new method based on quantum mechanics that enables extremely secure communications. The Finnish project is part of the EU’s EuroQCI initiative , which strives to create a quantum encrypted network covering the whole of the EU by

The blue-green sustainable proteins of seaweed may soon be on your plate

The protein in sea lettuce, a type of seaweed, is a promising complement to both meat and other current alternative protein sources. Seaweed also contains many other important nutrients, and is grown without needing to be watered, fertilised or sprayed with insecticides. However, the proteins are often tightly bound, and their full potential has not yet been realised on our plates.  But now researchers at Chalmers University of Technology, in Sweden, have found a new way to extract these proteins three times more efficiently than before – and this progress paves the way for

Curasight to present at HC Andersen Capital, BioStock Life Science Summit 2024, and Økonomisk Ugebrev Investor Conference

Copenhagen, Denmark, 14 November 2024 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) hereby announces that CEO Ulrich Krasilnikoff and CMO professor Andreas Kjær will present the company’s latest progress and strategy at HC Andersen Capital, BioStock Life Science Summit 2024 and Økonomisk Ugebrev Life Science Investor ConferenceThe presentations will include an update on the business progress made by the company during the first three quarters of 2024 and look ahead at the expected coming news flow. Management will give an overall update on the company’s pipeline based on

Nordic Aqua - Results for the third quarter 2024

Highlights · Good underlying operational and biological performance for all batches with excellent fish health and welfare · No commercial harvest in the third quarter. 651 tonnes biomass taken out in the quarter to optimize stock · Geosmin issue in July 2024, continuing into Q3 2024 causing lower turnover and no expected commercial harvest in H2 2024 · Q3 2024 biomass production of 1,005 tonnes and total biomass of 2,786 tonnes by quarter end, which is satisfactory given the reduced feeding due to geosmin · Stage 2 is on schedule and the first egg inlay for Stage 2 was

Kesko’s sales in October

Kesko’s sales increased by 6.2% in October, or by 2.2% in comparable terms.”Kesko’s sales grew by 6.2% in October. Sales grew in all divisions. In grocery trade, sales increased especially in Kespro’s foodservice business. In building and technical trade, sales in building and home improvement trade increased thanks to the Davidsen acquisition. In car trade, sales increased in all business areas. The number of delivery days was up by one in all divisions in October,” says Jorma Rauhala, Kesko’s President and CEO. Sales in the grocery trade division totalled €565.6 million in October, up

US-listed company intends to make an offer to take over a minimum of 51% of the shares in DecideAct A/S and has signed LOI

DecideAct A/S [ACT] NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN DecideAct A/S (the Company) has signed a letter of intent (LOI) with the purpose to receive a binding offer from a US-listed company. The potential acquirer specializes in investing in SaaS companies and wants to acquire a minimum of 51% of the outstanding warrants/shares in DecideAct A/S.Details of the offer: The LOI states that the acquirer intends to make a binding offer to the shareholders of DecideAct A/S by 1 December 2024, to acquire at least ACT shares incl. warrants equal to 11.208.447 ordinary shares in

US-listed company intends to make an offer to take over a minimum of 51% of the shares in DecideAct A/S and has signed LOI

DecideAct A/S [ACT] Company Announcement No. 10-2024: NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN DecideAct A/S (the Company) has signed a letter of intent (LOI) with the purpose to receive a binding offer from a US-listed company. The potential acquirer specializes in investing in SaaS companies and wants to acquire a minimum of 51% of the outstanding warrants/shares in DecideAct A/S.Details of the offer: The LOI states that the acquirer intends to make a binding offer to the shareholders of DecideAct A/S by 1 December 2024, to acquire at least ACT shares incl. warrants equal to

Lucara Announces Q3 2024 Results; Significant Shaft Sinking Progress

VANCOUVER, B.C., Nov. 13, 2024 /CNW/ (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm)   Lucara Diamond Corp. (“Lucara” or the “Company”) today reports its results for the quarter ended September 30, 2024. All amounts are in U.S. dollars unless otherwise noted.   Q3 2024 HIGHLIGHTS · Recoveries of two exceptional diamonds larger than 1,000 carats, including the epic 2,488-carat(1)  diamond and the 1,094-carat diamond. · A total of 116,221 carats of diamonds were sold, generating revenue of $44.3 million in Q3, 2024. · On October 4, 2024, the Company sold its interest in

Thanksgiving Decor Ideas

Thanksgiving is a time for family, friends, and feasting. As you prepare for this special occasion, consider enhancing your home with festive and heartwarming decorations. With so many options, how do you decide how to decorate for Thanksgiving this year?   [A thanksgiving table with food on it Description automatically generated]   Interior design expert Ryan McDonough at MyJobQuote.co.uk  has created this guide with a range of different Thanksgiving décor ideas to give you all the inspiration you need to get your home ready for the festive

Why You Should Consider a Job In The Skilled Trades

Skilled trades are responsible for the majority of things that we rely on in our lives and at work. Whether you are newly entering the workforce or you’re looking for a change of career, the skilled trades sector is teeming with opportunities.   Even if you have never thought of working as a tradesperson, it’s very likely that you can find something in this sector that excites you. With such a broad range of options, the opportunities are endless. From electrical work to carpentry to construction, there’s a wide variety of fields to explore.   [A person and person holding a red

Reporting of transactions made by persons discharging managerial responsibilities

SUGAR LAND, TEXAS, November 13, 2023 /PRNewswire/ - Noble Corporation plc ("Noble") (CSE: NOBLE, NYSE: NE) today announces that the persons listed below (the "PDMRs") have conducted transactions in the A ordinary shares of Noble each with a nominal value of USD 0.00001. Further details are set out in the notifications below, made in accordance with the requirements of article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (the "Market Abuse Regulation") as amended.   Notification and public disclosure in accordance with

There are no items matching the current filter
There are no more items matching the current filter
Back to top